chr17-50574450-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_018896.5(CACNA1G):​c.1141-1093A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.919 in 152,284 control chromosomes in the GnomAD database, including 64,413 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.92 ( 64413 hom., cov: 33)

Consequence

CACNA1G
NM_018896.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.671

Publications

5 publications found
Variant links:
Genes affected
CACNA1G (HGNC:1394): (calcium voltage-gated channel subunit alpha1 G) Voltage-sensitive calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division, and cell death. This gene encodes a T-type, low-voltage activated calcium channel. The T-type channels generate currents that are both transient, owing to fast inactivation, and tiny, owing to small conductance. T-type channels are thought to be involved in pacemaker activity, low-threshold calcium spikes, neuronal oscillations and resonance, and rebound burst firing. Many alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Sep 2011]
CACNA1G Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, PanelApp Australia, Ambry Genetics
  • spinocerebellar ataxia type 42
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Illumina
  • intellectual disability
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.962 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018896.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1G
NM_018896.5
MANE Select
c.1141-1093A>G
intron
N/ANP_061496.2
CACNA1G
NM_198377.3
c.1141-1093A>G
intron
N/ANP_938191.2
CACNA1G
NM_198396.3
c.1141-1093A>G
intron
N/ANP_938406.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1G
ENST00000359106.10
TSL:1 MANE Select
c.1141-1093A>G
intron
N/AENSP00000352011.5
CACNA1G
ENST00000507336.5
TSL:1
c.1141-1093A>G
intron
N/AENSP00000420918.1
CACNA1G
ENST00000507510.6
TSL:1
c.1141-1093A>G
intron
N/AENSP00000423112.2

Frequencies

GnomAD3 genomes
AF:
0.919
AC:
139787
AN:
152166
Hom.:
64352
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.970
Gnomad AMI
AF:
0.861
Gnomad AMR
AF:
0.933
Gnomad ASJ
AF:
0.922
Gnomad EAS
AF:
0.977
Gnomad SAS
AF:
0.918
Gnomad FIN
AF:
0.893
Gnomad MID
AF:
0.854
Gnomad NFE
AF:
0.885
Gnomad OTH
AF:
0.911
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.919
AC:
139907
AN:
152284
Hom.:
64413
Cov.:
33
AF XY:
0.920
AC XY:
68499
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.970
AC:
40331
AN:
41580
American (AMR)
AF:
0.933
AC:
14276
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.922
AC:
3200
AN:
3472
East Asian (EAS)
AF:
0.977
AC:
5045
AN:
5162
South Asian (SAS)
AF:
0.917
AC:
4425
AN:
4826
European-Finnish (FIN)
AF:
0.893
AC:
9471
AN:
10604
Middle Eastern (MID)
AF:
0.857
AC:
252
AN:
294
European-Non Finnish (NFE)
AF:
0.885
AC:
60194
AN:
68016
Other (OTH)
AF:
0.913
AC:
1928
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
587
1174
1762
2349
2936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.895
Hom.:
114197
Bravo
AF:
0.925
Asia WGS
AF:
0.950
AC:
3305
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
11
DANN
Benign
0.84
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs198547; hg19: chr17-48651811; API